COVID-19

News

COVID cough app Hyfe launches in UK and Ireland

A smartphone app that uses artificial intelligence to assess the sound of coughing has been launched in the UK, and according to its developer could be an early warning system for COVID-19

News

Goofy lama pulling face. Funny llama animal sticking tongue out

ExeVir ready for clinic with variant-targeting llama antibod...

Last year, Belgium’s ExeVir Bio raised 23 million euros ($27 million) to finance development of llama antibodies – and now it is ready to begin clinical development of a potential treatment

Views & Analysis

Pharma sales rep talking to a GP over video conferencing

Why pharma isn’t yet achieving digital excellence, and how i...

Nearly 70% of HCPs are now digital natives, with no interest in going back to pre-COVID sales engagement methods.

News

scientifically visualization of a coronavirus spike protein

EMA backs emergency use of Lilly’s COVID antibodies

The EMA’s human medicines committee has said two Eli Lilly antibodies are effective in people with COVID-19 who are at risk of developing severe disease, clearing the way for use in EU memb

Views & Analysis

The post-COVID face of pharma research and development

The acute phase of the COVID-19 pandemic not only brought delays, restrictions, and reconfigurations to pharmaceutical research & development in 2020, but also a more flexible response

News

Vaccine vial dose flu shot drug needle syringe,medical concept vaccination hypodermic injection treatment disease care hospital prevention immunization illness disease baby child.blue background

Germany backtracks on AZ COVID vaccine age restriction

Germany has decided that AstraZeneca’s COVID-19 vaccine should be approved for use in the over-65s after all, reversing its earlier restriction in that age group.

COVID cough app Hyfe launches in UK and Ireland

ExeVir ready for clinic with variant-targeting llama antibod...

Why pharma isn’t yet achieving digital excellence, and how i...

EMA backs emergency use of Lilly’s COVID antibodies

The post-COVID face of pharma research and development

Germany backtracks on AZ COVID vaccine age restriction

Obesity-focused biotech Kailera joins IPO queue in US

Using AI-driven synthetic personas to take your insights fur...

COVID-19

Editor's Picks